US SB694 | 2025-2026 | 119th Congress
Status
Sponsorship: Bipartisan Bill
Status: Introduced on February 24 2025 - 25% progression
Action: 2025-02-24 - Read twice and referred to the Committee on Finance.
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on February 24 2025 - 25% progression
Action: 2025-02-24 - Read twice and referred to the Committee on Finance.
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]
Summary
A bill to amend title XVIII of the Social Security Act to provide a phase-in for plasma-derived products under the manufacturer discount program.
Title
PLASMA Act Preserving Life-saving Access to Specialty Medicines in America Act
Sponsors
| Sen. Thom Tillis [R-NC] | Sen. Mark Kelly [D-AZ] | Sen. Ted Budd [R-NC] | Sen. Alex Padilla [D-CA] |
History
| Date | Chamber | Action |
|---|---|---|
| 2025-02-24 | Senate | Read twice and referred to the Committee on Finance. |
Same As/Similar To
HB1476 (Same As) 2025-02-21 - Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/119th-congress/senate-bill/694/all-info |
| Text | https://www.congress.gov/119/bills/s694/BILLS-119s694is.pdf |
